Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
PaperCitations, authors & open-access status
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 362 citations, 2014 year and bronze oa status.
362
Citations
2014
Year
bronze
OA Status